Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
91122 trials found · Page 127 of 4557
-
Chilling after heart stopping: could cooling save more brains?
Disease control Not yet recruitingThe IH-TTM trial is designed to determine whether survival with a favorable neurological outcome is improved by induced hypothermia at 33°C in comatose critically ill patients admitted after resuscitated in-hospital cardiac arrest (IHCA). Recent evidence suggests that targeted te…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New vaccine trial aims to clear Cancer-Causing HPV infections
Disease control Not yet recruitingThis research is being done to test the safety and feasibility of an investigational DNA vaccine called pBI-11 and to find out what effects, if any, it has on women with persistent human papillomavirus 16 (HPV16+) and/or human papillomavirus (HPV18+) cervical infection. The DNA …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
Could Late-Stroke patients still benefit from clot removal? new trial aims to find out
Disease control Recruiting nowSELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving bette…
Phase: NA • Sponsor: Amrou Sarraj • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC
-
Could ozempic help obese men become fathers?
Disease control Not yet recruitingWhy is this study being done? Obesity can harm men's fertility by lowering sperm quality and hormone levels, making it harder to have children. Weight loss through diet and exercise helps, but it's often hard to stick with. New medicines called GLP-1 receptor agonists, like semag…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
School-Based malaria treatment aims to shield entire villages
Prevention Not yet recruitingThe CRITICal study aims to estimate the effectiveness of intermittent preventive treatment in school children (IPTsc) with dihydroartemisinin-piperaquine (DP) for reducing community level malaria burden. Given that school-aged children are the primary drivers of transmission, the…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Apr 30, 2026 15:51 UTC
-
New radiation therapy shows promise for inoperable liver tumors
Disease control Not yet recruitingThis is a prospective, single-blinded, single-arm, open-label Phase II trial of trans-arterial radiation segmentectomy using Yttrium-90 glass microspheres (TheraSphere®) for Hepatocellular Carcinoma (HCC) participants with unresectable Barcelona clinic liver cancer (BCLC) stage A…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New shot could bring relief to millions with severe eczema
Disease control Not yet recruitingRationale (What is the reason for this study?) Atopic dermatitis (AD) is a condition that makes the skin dry and itchy and is the most common skin condition that causes redness and irritation. The exact cause of AD is unclear but genetic and environmental factors are believed to…
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated May 07, 2026 15:33 UTC
-
New combo attack on prostate cancer: drug, surgery, and radiation
Disease control Not yet recruitingProstate cancer represents the second most common malignancy in men worldwide. Oligometastatic prostate cancer (OMPC), defined as a transitional state between localized and widespread metastatic disease (≤10 metastatic lesions without visceral metastases), exhibits relatively ind…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 07, 2026 15:32 UTC
-
Targeted drug and radiation team up to fight aggressive kidney cancer
Disease control Not yet recruitingThis randomized, open-label, multicenter phase II study is designed to compare disitamab vedotin plus radiotherapy with gemcitabine plus carboplatin as adjuvant treatment in patients with HER2-expressing upper tract urothelial carcinoma after radical nephroureterectomy (RNU). Eli…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
New telehealth program aims to bring HIV prevention to hidden trans communities
Prevention Not yet recruitingThe prevalence of HIV (Human Immunodeficiency Virus) and STIs (Sexually Transmitted Infections) is very high in the trans population, due to multifactorial components. The main risk factors for HIV in this population are unprotected receptive and insertive anal intercourse, mult…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated May 05, 2026 11:54 UTC
-
New combo therapy aims to boost depression treatment success
Symptom relief Recruiting nowRepetitive Transcranial Magnetic stimulation (rTMS) is an FDA-approved therapy for treatment resistant depression (TRD) that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. But studies of rTMS alone show remission rates of \~…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC
-
New combo therapy aims to shrink inoperable liver tumors
Disease control Not yet recruitingThis is a prospective, single-arm, phase II clinical study designed to evaluate the efficacy and safety of low-dose bevacizumab plus atezolizumab combined with transarterial chemoembolization followed by hepatic arterial infusion chemotherapy (TACE-HAIC) as first-line treatment f…
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
AI and CT scans join forces to catch lung cancer early in latin america
Diagnosis Not yet recruitingProspective study to assess lung cancer screening with low dose CT scan (LDCT) in Latin America (LATAM) and prospectively evaluate chest-XRay analyzed with artificial intelligence (AI) using qXRin (QURE ai) at the initial visit correlating with the findins of the initial LDCT in …
Sponsor: Latin American Consortium for the Lung Cancer Research • Aim: Diagnosis
Last updated May 04, 2026 16:23 UTC
-
Dental check before heart surgery may save lives
Prevention Not yet recruitingThis randomized, multicenter, open-label trial evaluates whether preoperative dental screening improves outcomes in patients undergoing surgical or transcatheter cardiac valve intervention. Participants are randomized 1:1 to preoperative dental screening or no screening. The prim…
Phase: NA • Sponsor: Region Skane • Aim: Prevention
Last updated May 06, 2026 16:01 UTC
-
Smarter radiation: fewer sessions, fewer side effects for prostate cancer
Disease control Not yet recruitingThis is a single arm trial that is recruiting a total of 50 participants that have been diagnosed with prostate bed (where the prostate was taken out) or regional (surrounding lymph nodes) recurrence of a prostate cancer following surgery. Salvage radiation treatment represents t…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Surgeons in chengdu to operate on patients 2,000 km away using 5G robot
Disease control Not yet recruitingHepatic echinococcosis (HE) is a serious endemic parasitic disease in high-altitude regions like Xizang. Radical hepatectomy is the primary curative treatment, but expert resources are often concentrated in large medical centers. This prospective, single-arm study aims to evaluat…
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New hope for seniors with hard-to-treat lymphoma: drug combo targets double/triple-hit cancers
Disease control Not yet recruitingThis is an open-label, multicenter clinical study for patients aged 65 and above with double/triple-hit diffuse large B-cell lymphoma who are not suitable for transplantation. The study employs a 6-cycle CL-Pola-R-CHP regimen, with cycles repeated every 21 days.
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 07, 2026 15:35 UTC
-
AI assistant aims to cut heart surgery complications
Disease control Not yet recruitingThis is a single-center, prospective, randomized, open-label, parallel-controlled clinical study to evaluate the effectiveness of a large language model (LLM)-based intelligent health management assistant in the life-cycle health management of patients after cardiac surgery. A to…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Engineered immune cells take on Hard-to-Treat pancreatic cancer
Disease control Not yet recruitingChemotherapy is the first-line treatment for advanced-stage pancreatic cancer patients. However, drug resistance always occurs within 6 months. For these patients, no effective treatment is available. Chimeric antigen receptor macrophage targeting C-MET( CAR-M-C-MET) is a novel c…
Phase: PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New scan spots hidden heart clots in rare disease
Diagnosis Recruiting nowThe primary goal of this pilot study is to determine whether \[64Cu\]FBP8, a novel fibrin-binding positron emission tomography (PET) probe, can identify intracardiac thrombi when paired with simultaneous hybrid cardiac PET/MRI in twenty (20) individuals with transthyretin or ligh…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated May 04, 2026 16:22 UTC